4 min read
Diabetes Awareness Month: Why It Matters in Your Practice
Terri Schmitt PhD, APRN, FNP-BC, FAANP, Executive Director, NPACE
:
November 20, 2026
Diabetes Awareness Month: Why It Matters in Your Practice
As a clinical provider who helps manage diabetes patients, this month is particularly important to me. For all U.S. clinicians, this month should highlight how diabetes numbers continue to rise. Currently, more than 40 million people in the United States now live with diabetes, and roughly 1 in 4 of them do not know it.1 For advanced practice clinicians, this means diabetes touches nearly every patient panel and every practice day, from pediatric and prenatal care to geriatrics. To convey the importance of this group of diseases, I wanted to cover some current statistics, definitions on diabetes types, and a few guidelines and resources.
Types of Diabetes: A Quick Refresher
The American Diabetes Association (ADA) groups diabetes into four categories: Type 1, Type 2, specific types due to other causes, and gestational diabetes. However classification is not always clear at presentation with up to 40% of adults with new type 1 diabetes are initially misdiagnosed.5
Diabetes By the Numbers
- 40.1 million persons have diabetes.1
- 27.6% of all adults with diabetes are undiagnosed.1
- Over 300,000 children and adolescents have Type 1 diabetes.1
- In Youth, incidence cases rose around 25 for T1DM and 5.3% for T2DM on average from 2002 to 2018.2
- Nearly 115 million U.S. adults have prediabetes.1
- Gestational diabetes rose from 58 to 79 per 1,000 births (2016 to 2024), a 36% increase.3
- Globally, 589 million adults (ages 20 to 79) live with diabetes; 252 million are undiagnosed; projected 853 million by 2050.4
Type 1 diabetes (T1DM): Autoimmune destruction of pancreatic beta cells, usually leading to absolute insulin deficiency. It accounts for 5% to 10% of diabetes.5 Note three stages in diagnosis: Stage 1 (two or more islet autoantibodies, normal glucose), stage 2 (autoantibodies with dysglycemia), and stage 3 (symptomatic hyperglycemia meeting diagnostic criteria).5 Recommended autoantibodies are insulin, GAD, IA-2, and ZnT8.5
Type 2 diabetes (T2DM): We now know this type of diabetes is a complex metabolic disease that includes insulin resistance, over secretion of glucagon, non-response, blunted response of incretin hormones, and progressive loss of beta-cell insulin secretion, usually on a background of insulin resistance and accounts for 90% to 95% of diabetes.5
Latent autoimmune diabetes in adults (LADA): A slowly progressive autoimmune diabetes with adult onset. The ADA classifies all autoimmune diabetes as type 1 regardless of age but accepts the term LADA in practice because it raises awareness of autoimmunity in adults.5 Clinicians should be cautioned that non-validated antibody tests can mislabel people with either T2DM. Highly sensitive and appropriate antibody assays are needed to diagnose properly as well as a fasting insulin level and c-peptide testing.
Maturity-onset diabetes of the young (MODY): This unique type of diabetes is genetic as a group of monogenic, usually autosomal dominant, forms of diabetes that account for less than 5% of all diabetes.6 The most common genes are HNF1A and GCK(each 30% to 60% of MODY cases) and HNF4A (5% to 10%).6 Correct diagnosis matters as different types require different treatment. GCK-MODY usually needs no medication, and HNF1A- and HNF4A-MODY often respond well to sulfonylureas.6Suspect MODY with a parent who has diabetes, an A1C below 7.5% at diagnosis, or negative islet autoantibodies.5
Type 3c (pancreatogenic) diabetes: Diabetes caused by disease of the exocrine pancreas, such as chronic pancreatitis, cystic fibrosis, hemochromatosis, pancreatic cancer, or pancreatectomy. Chronic pancreatitis is the most common cause. In one German referral-center study, almost 10% of people with diabetes met type 3c criteria, and most had been labeled type 2. Loss of glucagon can cause brittle glycemia and hypoglycemia, and pancreatic enzyme replacement is often part of care.7
Gestational diabetes mellitus (GDM): This type of diabetes diagnosis comes in the second or third trimester of pregnancy after glucose tolerance testing, but was not present prior to pregnancy. Having gestational diabetes raises risk of later development of Type 2 diabetes.5
Other Types: Drug-induced diabetes includes specific medication or medical causes. For example, glucocorticoids, second-generation antipsychotics, and immune checkpoint inhibitors are known causes as well as cystic fibrosis-related diabetes, and posttransplant diabetes. Immune checkpoint inhibitor diabetes occurs in 0.6% to 1.4% of treated patients and can present as DKA.5
Guidelines and Resources
The ADA annually publishes the Standards of Care in Diabetes, 2026 and these guidelines are the core reference for diagnosis and management of diabetes for U.S. clinicians. Updates in 2026 included early CGM at diagnosis for anyone who may benefit, obesity treatment in type 1 diabetes, revised blood pressure goals, and expanded type 1 screening guidance.7
Centers for Disease Control and Prevention (CDC) has several resources with statistics and clinical guidelines including:
- National Diabetes Statistics Report
- Clinical guidance for health care providers
- National Diabetes Prevention Program: lifestyle change program
- Diabetes self-management education and support (DSMES)
Global data sources include the International Diabetes Federation: IDF Diabetes Atlas, 11th edition
References
- Centers for Disease Control and Prevention. (2026, September 16). National diabetes statistics report. U.S. Department of Health and Human Services. https://www.cdc.gov/diabetes/php/data-research/index.html
- Wagenknecht, L. E., Lawrence, J. M., Isom, S., et al. (2023). Trends in incidence of youth-onset type 1 and type 2 diabetes in the USA, 2002–18: Results from the population-based SEARCH for Diabetes in Youth study. The Lancet Diabetes & Endocrinology, 11(4), 242–250. https://doi.org/10.1016/S2213-8587(23)00025-6
- Lam, E. L., Walker, J., Wang, M.C. et al. (2025). Gestational diabetes in the US from 2016 to 2024. JAMA Internal Medicine. Advance online publication. https://doi.org/10.1001/jamainternmed.2025.7055
- International Diabetes Federation. (4/7/2025). Over 250 million people worldwide unaware they have diabetes, according to new IDF research [IDF Diabetes Atlas, 11th ed.]. https://idf.org/news-and-resources/news/idf-diabetes-atlas-11th-edition/
- American Diabetes Association Professional Practice Committee for Diabetes. (2026). 2. Diagnosis and classification of diabetes: Standards of Care in Diabetes–2026. Diabetes Care, 49 (Suppl. 1), S27–S49. https://doi.org/10.2337/dc26-S002
- Hoffman, L. S., Fox, T. J., Anastasopoulou, C., & Jialal, I. (2023). Maturity onset diabetes in the young. In StatPearls. StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK532900/
- American Diabetes Association. (12/8/2025). American Diabetes Association releases Standards of Care in Diabetes–2026 [Press release]. https://diabetes.org/newsroom/press-releases/american-diabetes-association-releases-standards-care-diabetes-2026